PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
54.43%
Positive growth while CRK shows revenue decline. John Neff would investigate competitive advantages.
107.49%
Cost increase while CRK reduces costs. John Neff would investigate competitive disadvantage.
5.28%
Positive growth while CRK shows decline. John Neff would investigate competitive advantages.
-31.82%
Margin decline while CRK shows 13.47% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.94%
Other expenses reduction while CRK shows 83.69% growth. Joel Greenblatt would examine efficiency.
-134.85%
Operating expenses reduction while CRK shows 75.50% growth. Joel Greenblatt would examine advantage.
-3.03%
Total costs reduction while CRK shows 9.33% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-48.89%
Both companies reducing D&A. Martin Whitman would check industry patterns.
49.61%
EBITDA growth while CRK declines. John Neff would investigate advantages.
68.18%
EBITDA margin growth while CRK declines. John Neff would investigate advantages.
492.56%
Operating income growth while CRK declines. John Neff would investigate advantages.
283.71%
Operating margin growth while CRK declines. John Neff would investigate advantages.
150.63%
Other expenses growth less than half of CRK's 455.00%. David Dodd would verify if advantage is sustainable.
286.57%
Pre-tax income growth exceeding 1.5x CRK's 28.63%. David Dodd would verify competitive advantages.
150.32%
Pre-tax margin growth exceeding 1.5x CRK's 79.89%. David Dodd would verify competitive advantages.
596.96%
Tax expense growth above 1.5x CRK's 28.43%. Michael Burry would check for concerning trends.
557.39%
Net income growth exceeding 1.5x CRK's 28.74%. David Dodd would verify competitive advantages.
325.69%
Net margin growth exceeding 1.5x CRK's 80.05%. David Dodd would verify competitive advantages.
411.11%
EPS growth exceeding 1.5x CRK's 26.11%. David Dodd would verify competitive advantages.
423.22%
Diluted EPS growth exceeding 1.5x CRK's 33.53%. David Dodd would verify competitive advantages.
26.55%
Share count reduction below 50% of CRK's 0.79%. Michael Burry would check for concerns.
25.33%
Diluted share increase while CRK reduces shares. John Neff would investigate differences.